Pharmicell Co., Ltd. (KRX:005690)
South Korea · Delayed Price · Currency is KRW 19,770
-30 (-0.15%)
At close: Apr 29, 2026
Pharmicell Market Cap
Pharmicell has a market cap or net worth of 1.19 trillion as of April 29, 2026. Its market cap has increased by 93.26% in one year.
Market Cap
1.19T
Enterprise Value
n/a
Revenue
23.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
19,770.00
Market Cap Chart
Since August 29, 1995, Pharmicell's market cap has increased from 40.96B to 1.19T, an increase of 2,796.19%. That is a compound annual growth rate of 11.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.19T | 36.27% |
| Dec 30, 2025 | 871.86B | 75.48% |
| Dec 30, 2024 | 496.83B | 36.41% |
| Dec 28, 2023 | 364.22B | -46.28% |
| Dec 29, 2022 | 678.05B | -13.33% |
| Dec 30, 2021 | 782.30B | -24.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hugel | 2.88T |
| Orum Therapeutics | 1.79T |
| Chabiotech | 1.66T |
| MEDIPOST | 1.03T |
| GI Innovation | 1.03T |
| Onconic Therapeutics | 1.01T |
| Medy-Tox | 705.99B |
| Proteina | 696.84B |